Maxcyte Inc., based in Gaithersburg, Maryland, specializes in cell engineering and the development of innovative cell-based therapies. The company focuses on providing advanced technology platforms that facilitate the discovery and development of biologics, including therapeutic proteins and cell therapies. Maxcyte's proprietary flow electroporation technology enables efficient delivery of nucleic acids into cells, supporting research and development in various fields such as oncology, immunology, and regenerative medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

39 Patents

#11 in Gaithersburg, MD

#104 in Maryland

#8,830 in US

#17,465 in the World

Gaithersburg, MD, United States of America

Maxcyte Inc.

Forward Citations = 980

21 inventors:

James William Luther (20 out of 29 patents)

Bertold Engler (20 out of 20 patents)

Thomas Alan Peach (20 out of 20 patents)

4. Andrea Besana (20 out of 28 patents)

5. Nicholas Chopas (12 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Maxcyte Inc.. Retrieved from https://idiyas.com/company/maxcyte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

8 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]